231 related articles for article (PubMed ID: 8663343)
1. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
[TBL] [Abstract][Full Text] [Related]
2. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells.
Chen C; Wang XF; Sun L
J Biol Chem; 1997 May; 272(19):12862-7. PubMed ID: 9139748
[TBL] [Abstract][Full Text] [Related]
4. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
[TBL] [Abstract][Full Text] [Related]
5. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.
Sun L; Wu G; Willson JK; Zborowska E; Yang J; Rajkarunanayake I; Wang J; Gentry LE; Wang XF; Brattain MG
J Biol Chem; 1994 Oct; 269(42):26449-55. PubMed ID: 7929366
[TBL] [Abstract][Full Text] [Related]
6. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
Nørgaard P; Spang-Thomsen M; Poulsen HS
Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
[TBL] [Abstract][Full Text] [Related]
7. Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells.
Ammanamanchi S; Tillekeratne MP; Ko TC; Brattain MG
Cancer Res; 2004 Apr; 64(7):2509-15. PubMed ID: 15059906
[TBL] [Abstract][Full Text] [Related]
8. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
Jakowlew SB; Moody TW; You L; Mariano JM
Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
[TBL] [Abstract][Full Text] [Related]
9. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors.
Rodriguez C; Chen F; Weinberg RA; Lodish HF
J Biol Chem; 1995 Jul; 270(27):15919-22. PubMed ID: 7608141
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
Okamoto M; Oyasu R
Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
[TBL] [Abstract][Full Text] [Related]
11. 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.
Ammanamanchi S; Brattain MG
J Biol Chem; 2001 Aug; 276(35):32854-9. PubMed ID: 11443124
[TBL] [Abstract][Full Text] [Related]
12. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG
Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155
[TBL] [Abstract][Full Text] [Related]
13. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
Wikström P; Lindh G; Bergh A; Damber JE
Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
[TBL] [Abstract][Full Text] [Related]
14. Control of type II transforming growth factor-beta receptor expression by integrin ligation.
Wang D; Sun L; Zborowska E; Willson JK; Gong J; Verraraghavan J; Brattain MG
J Biol Chem; 1999 Apr; 274(18):12840-7. PubMed ID: 10212271
[TBL] [Abstract][Full Text] [Related]
15. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
Ko Y; Koli KM; Banerji SS; Li W; Zborowska E; Willson JK; Brattain MG; Arteaga CL
Int J Oncol; 1998 Jan; 12(1):87-94. PubMed ID: 9454891
[TBL] [Abstract][Full Text] [Related]
16. Cell-cycle-dependent expression of transforming growth factor beta type I receptor correlates with differential proliferative effects of TGFbeta1 in articular chondrocytes.
Boumediene K; Félisaz N; Pujol JP
Exp Cell Res; 1998 Aug; 243(1):173-84. PubMed ID: 9716461
[TBL] [Abstract][Full Text] [Related]
17. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells.
Periyasamy S; Sun L; Gentry LE; Brattain MG
J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
Jakowlew SB; Moody TW; Mariano JM
Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells.
Sun L; Chen C
J Biol Chem; 1997 Oct; 272(40):25367-72. PubMed ID: 9312157
[TBL] [Abstract][Full Text] [Related]
20. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity.
Wang J; Sergina N; Ko TC; Gong J; Brattain MG
J Biol Chem; 2004 Sep; 279(38):40237-44. PubMed ID: 15271980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]